- Home
- SRTS vs IOBT Comparison
SRTS vs IOBT Comparison
Compare SRTS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- IOBT
- Stock Information
- Founded
- SRTS 2010
- IOBT 2014
- Country
- SRTS United States
- IOBT Denmark
- Employees
- SRTS N/A
- IOBT N/A
- Industry
- SRTS Medical/Dental Instruments
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- IOBT Health Care
- Exchange
- SRTS Nasdaq
- IOBT Nasdaq
- Market Cap
- SRTS 52.9M
- IOBT 50.5M
- IPO Year
- SRTS 2016
- IOBT 2021
- Fundamental
- Price
- SRTS $3.19
- IOBT $0.85
- Analyst Decision
- SRTS Strong Buy
- IOBT Buy
- Analyst Count
- SRTS 3
- IOBT 4
- Target Price
- SRTS $8.00
- IOBT $3.50
- AVG Volume (30 Days)
- SRTS 79.8K
- IOBT 7.4M
- Earning Date
- SRTS 11-06-2025
- IOBT 11-07-2025
- Dividend Yield
- SRTS N/A
- IOBT N/A
- EPS Growth
- SRTS N/A
- IOBT N/A
- EPS
- SRTS N/A
- IOBT N/A
- Revenue
- SRTS $37,564,000.00
- IOBT N/A
- Revenue This Year
- SRTS N/A
- IOBT N/A
- Revenue Next Year
- SRTS $47.33
- IOBT N/A
- P/E Ratio
- SRTS N/A
- IOBT N/A
- Revenue Growth
- SRTS 3.29
- IOBT N/A
- 52 Week Low
- SRTS $3.03
- IOBT $0.32
- 52 Week High
- SRTS $9.33
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- SRTS 43.60
- IOBT 46.05
- Support Level
- SRTS $3.15
- IOBT $0.83
- Resistance Level
- SRTS $3.45
- IOBT $1.23
- Average True Range (ATR)
- SRTS 0.15
- IOBT 0.13
- MACD
- SRTS 0.00
- IOBT 0.05
- Stochastic Oscillator
- SRTS 8.57
- IOBT 43.53
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.